Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Vericel Corp Director's Dealing 2020

Feb 13, 2020

31799_dirs_2020-02-13_86d3f088-7971-412e-b48f-4c7082c70439.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vericel Corp (VCEL)
CIK: 0000887359
Period of Report: 2020-02-11

Reporting Person: Colangelo Dominick (N/A)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-02-11 Stock Option (right to buy) $18 A 219445 Acquired 2030-02-11 Common Stock (219445) Direct
2020-02-11 Restricted Stock Unit $ A 30000 Acquired Common Stock (30000) Direct
2020-02-11 Stock Option (right to buy) $18 A 5555 Acquired 2030-02-11 Common Stock (5555) Direct

Footnotes

F1: These options shall begin vesting on February 11, 2020 and shall vest and become exercisable in equal quarterly installments over the course of the following four (4) year period.

F2: Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation.

F3: These RSUs vest in four annual installments with the initial vesting of RSUs granted to the Reporting Person on February 11, 2021. The remaining RSUs will vest in annual installments on February 11, 2022, February 11, 2023, and February 11, 2024, respectively.

F4: No expiration date for this type of award.